Stay updated with breaking news from Ludwig Burgerediting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares in Zealand Pharma soared 34% on Monday after an experimental weight-loss drug it is developing with Boehringer Ingelheim yielded what they called "groundbreaking"...
FRANKFURT (Reuters) -Germany's federal drug regulator on Wednesday urged pharmacies and drug distributors to be vigilant after wholesale batches of counterfeit versions of Novo Nordisk's diabetes drug Ozempic were found in the country. In a statement, BfArM said it will lead the investigation, taking over from regional state authorities that were previously in charge of the probe. BfArM said there was no evidence that any fake Ozempic had been sold, but distributors and pharmacies should be on t
FRANKFURT (Reuters) -Germany's BioNTech, Pfizer's partner on COVID-19 vaccines, cut its drug development budget for this year after quarterly revenues were hurt by a plunge in pandemic-related demand. Second-quarter revenue dropped to 167.7 million euros ($184 million) from 3.2 billion euros a year earlier, as write-offs on Pfizer's assets ate into profit share payments that BioNTech is entitled to receive from its U.S. partner. "With some uncertainty on the revenue line, we are also carefully watching our spending by revisiting our cost base," said finance chief Jen...
Bayer subsidiary BlueRock has become the first company to report initial success treating Parkinson's disease in humans using an experimental stem cell therapy, the drugmaker said on Wednesday. The hunt for Parkinson's treatments has seen many setbacks over decades. Bayer said that one year into a Phase I trial with 12 volunteers, BlueRock's therapy was shown to be well-tolerated and that transplanted cells grew as intended in patients' brains.
FRANKFURT (Reuters) -Drugmaker Bayer said on Wednesday that initial testing on 12 volunteers showed its experimental stem cell therapy to treat Parkin...